Cavity Enhanced MicroArray

Cavity Enhanced MicroArray as an Ultra-sensitive Tool to aid Sepsis Diagnosis

Cavity Enhanced MicroArray

The CE-MicroArray project will utilize existing technology from clinical chemistry, microplate readers and cavity enhanced spectroscopy in a truly novel way to develop more sensitive, accurate, faster and more useful diagnostic platform for sepsis. Sepsis is a life-threatening illness caused by the body’s overreaction to an infection and can be triggered either directly by infection or may occur after medical treatment or surgery. The mortality rate in patients admitted to hospital with severe sepsis is 28-50% and it remains the most prevalent cause of death in non-coronary intensive care units. To reduce costs and provide better treatment to patients, early, accurate diagnosis is critically important.

Cavity Enhanced MicroArray is developing a new spectroscopic technique of Cavity Enhanced Absorption Spectrometry (CEAS) for application in bioassay. The work builds on US patent (US8325342B2) on the use of CEAS in microenvironments, as well as three additional patent filings as part of a patent family for the CEAS technology which has been exclusively licensed to Anasyst, a spin-out company from Teesside University. The project is being led by Teesside University, with six SME partners and two higher education institutions from across Europe. The aim is to strengthen the innovation capacity of SMEs in Europe and their contribution to the development of new technology based products and markets.

Project Duration: 24 Months
Project Start: February 2014
Principal Investigator: Dr Meez Islam
Funding: €1,1139,066

This project is funded by the European Commission’s Seventh Framework Programme FP7-SME-2013 under grant agreement 606618.

More details about the Cavity Enhanced MicroArray project